| Ramakrishna Prasad Vallurupalli, MD | |
|
525 Couch Ave, Kirkwood, MO 63122-5536 | |
| (314) 966-1500 | |
| (314) 966-1681 |
| Full Name | Ramakrishna Prasad Vallurupalli |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 525 Couch Ave, Kirkwood, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114974938 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | R6A13 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ramakrishna Prasad Vallurupalli, MD 1836 Lackland Hill Pkwy, Attention: Credentialing Department, Saint Louis, MO 63146-3572 Ph: (314) 989-0300 | Ramakrishna Prasad Vallurupalli, MD 525 Couch Ave, Kirkwood, MO 63122-5536 Ph: (314) 966-1500 |
News Archive
Terminally ill patients and their family caregivers often feel abandoned by their doctors and feel a sense of "unfinished business with them, according to a new study by an oncologist at the Seattle Cancer Care Alliance.
HDL cholesterol (HDL-C), or "good" cholesterol, carries excess cholesterol - that might otherwise block arteries - from blood vessels back to the liver for processing and elimination.
Advanced BioMedical Technologies Inc. announced that it has completed all 60 human clinical test cases of its PA Absorbable Orthopaedic Implant Screw according to the regulations set out by the China State Food and Drug Administration (SFDA). The actual number of test cases that have been taken in is 63.
The U.S. Food and Drug Administration today announced that the manufacturers of drugs containing the active ingredient carbamazepine have agreed to add to the drugs' labeling a recommendation that, before starting therapy with the drugs, patients with Asian ancestry get a genetic blood test that can identify a significantly increased risk of developing a rare, but serious, skin reaction.
Pro-Pharmaceuticals, the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that on December 17, 2010, Company representatives met with officials from the U.S. Food & Drug Administration to present its Phase III clinical development program for DAVANAT.
› Verified 4 days ago
Savitri Jain, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 525 Couch Ave, Kirkwood, MO 63122 Phone: 314-996-1500 Fax: 314-966-1681 | |
Richard Muchnick, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 4 Country Club Ter, Kirkwood, MO 63122 Phone: 314-420-2631 | |
William W Sullivan, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 525 Couch Ave, Kirkwood, MO 63122 Phone: 314-966-1500 Fax: 314-966-1681 | |
Rajesh Swaminathan, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 525 Couch Ave, Kirkwood, MO 63122 Phone: 314-966-1500 | |
Leslie B Wilson, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 525 Couch Ave, Kirkwood, MO 63122 Phone: 314-966-1500 Fax: 314-966-1681 |